S
tereotactic radiosurgery is a safe and effective treatment for brain AVMs. 3, 5, 8, 11 The risk of hemorrhage, a cause of poor outcomes, 8 significantly decreases even before angiographic obliteration after radiosurgery for ruptured AVMs. 4 Therefore, considering the risk of rebleeding, it seems reasonable to apply radiosurgery as soon as possible after hemorrhage. However, the presence of a hematoma is responsible for 9% of radiosurgical failure. 1, 9 When a hematoma compresses vessels within the nidus, its resolution may give rise to re-expansion of the AVM into the space that was not subjected to radiosurgery. Because such hematomas in the acute phase can also cause instability in neurological status as well as the compression of the AVM nidus, radiosurgery is usually applied several months after hemorrhage when the deteriorated neurology and compression of the AVM nidus have resolved. However, no evidence exists on the optimal timing to perform GKS after hemorrhage caused by brain AVMs, and, practically, the timing is determined based on the personal experience of each radiosurgeon. In this study, the authors investigated the benefit of waiting for several months for hematoma absorption, and aimed to clarify the optimal timing of GKS after AVM hemorrhage.
Methods
Between July 1990 and June 2003, 531 consecutive patients with brain AVMs underwent GKS at the University of Tokyo Hospital. We retrospectively studied 211 patients who had presented with hemorrhage and underwent GKS as the initial treatment. We generally waited for 3 months after hemorrhage until GKS for ruptured AVMs, while some patients underwent GKS < 3 months after hemorrhage and some others were referred to our institute > 3 months after hemorrhage. We usually did not wait > 3 months after referral to our institute.
During GKS, the dose applied to the AVM margin was designed to be ≥ 20 Gy by using 50% isodose lines Object. Optimal timing of Gamma Knife surgery (GKS) after hemorrhage from brain arteriovenous malformations (AVMs) is unclear and of concern to neurosurgeons because GKS is usually performed after absorption of the hematoma. The authors investigated whether waiting for hematoma absorption is beneficial and aimed to clarify the optimal treatment timing.
Methods. The authors retrospectively studied 211 patients with AVMs who presented with hemorrhage and underwent GKS as the initial treatment. Patients were categorized into 3 groups according to the interval between the time of first hemorrhage and GKS, as follows: Group 1, 0-3 months (70 patients); Group 2, 3-6 months (62 patients); and Group 3, > 6 months (79 patients). The obliteration rates, number of hemorrhages before and after GKS, and complication rates were compared between these 3 groups. The authors also analyzed a subgroup of 127 patients who presented with intracerebral hemorrhage (ICH) to identify the influence of ICH on outcome.
Results. After a median follow-up of 6.3 years, the rates of obliteration, hemorrhage after treatment, and complication were not significantly different between the 3 groups even though the patients with a longer interval before GKS (Group 3) had more AVMs in eloquent areas and neurological deficits. However, the numbers of patients with preoperative hemorrhage in the interval before GKS was significantly higher in Group 3 (1, 3, and 20 patients in Group 1, 2, and 3, respectively). These results were similar in the analyses of 127 patients presenting with ICH.
Conclusions. No benefit was detected in waiting for hematoma absorption until GKS after hemorrhage from AVM. Because of higher hemorrhagic risk until GKS > 6 months after hemorrhage, the authors recommend GKS within 6 months after hemorrhage. in principle. However, doses were occasionally reduced according to the volume and location of AVMs or patient status. Until 1992, after patients underwent GKS serial cerebral angiography was performed annually. Beginning in 1993, patients underwent angiography when the obliteration of an AVM nidus was strongly suggested on CT or MR imaging series that were performed every 6 months. Obliteration of an AVM was diagnosed based on cerebral angiography.
Patients were categorized into 3 groups according to the interval between the time of first hemorrhage and GKS, as follows: Group 1, 0-3 months; Group 2, 3-6 months; and Group 3, > 6 months. The rate of obliteration, hemorrhage before and after treatment, and complication were compared between these 3 groups. To identify the influence of ICH on treatment outcomes, we analyzed a subgroup of 127 patients who presented with ICH. The log-rank test was used to analyze the incidence of obliteration, and the hemorrhage and complication rates were compared by using chi-square test.
Results
The interval between the first hemorrhage and the time of GKS ranged from 1 month to 27 years (median 4 months). As a consequence, Groups 1, 2, and 3 consisted of 70, 62, and 79 patients, respectively (Table 1) . No statistically significant difference was found between 3 groups in regard to patient age, number of female patients, AVM volume, number of patients harboring an AVM with deep venous drainage, Spetzler-Martin grade, 10 or margin dose. However, those patients with a longer interval before GKS harbored more AVMs in eloquent areas (p < 0.01) and were more likely to present with neurological deficits at time of treatment (p = 0.04; Table 1 ). The median follow-up period for all 211 patients was 6.3 years after GKS. In the group of patients who underwent GKS > 6 months after hemorrhage (Group 3), the time interval was between hemorrhage and referral to our institute for the majority of patients.
The obliteration rate ranged from 70 to 84% at 4 years in the 3 groups (Fig. 1) . Fourteen patients suffered a hemorrhage after GKS, and the rate of hemorrhage after GKS until obliteration ranged from 6 to 8%. Three patients (1 patient in each group) suffered a hemorrhage after obliteration. Complications were observed in 12 patients, and the rate of complication ranged from 3 to 8% in the 3 groups. All these parameters were not significantly different between 3 groups (Table 2) . However, the rate of hemorrhage in the period between the time of first hemorrhage and GKS was significantly higher in Group 3 (1, 3, and 20 patients in Group 1, 2, and 3, respectively; p < 0.01). Among 211 patients, 127 patients (60%) presented with ICH. In this subgroup, the rates of obliteration (Fig.  2) , hemorrhage after treatment, and complication were also not significantly different between the 3 groups. However, the rate of hemorrhage in the period between the time of first hemorrhage and GKS was also significantly higher in Group 3 (0, 1, and 9 patients in Group 1, 2, and 3, respectively; p < 0.01) ( Table 2) .
Discussion
We could not detect the clear benefit of waiting for several months for hematoma absorption until GKS after hemorrhage from AVMs. The rates of obliteration, posttreatment hemorrhage, and complication were not significantly different according to the timing of GKS. Because the presence of hematoma compressing the AVM nidus can cause radiosurgical failure, 1, 9 it is possible that waiting is beneficial in a particular case. However, its low proportion as a whole might be one of the reasons for a lack of statistically significant results. Because the group of patients with longer intervals (Group 3) had more AVMs in eloquent areas and were more likely to present with neurological deficits at the time of treatment, our results might be a consequence of our appropriate decision of the optimal timing. To clarify more detailed outcome, it would be necessary to further investigate the determinant factor of the interval, change in angiographic appearance of AVM after hematoma absorption, or the process of neurological recovery after hemorrhage until GKS. Because this is a retrospective case series, different patient populations from other institutes might lead to different results. The longer the interval between hemorrhage and GKS was, the higher the risk of pre-GKS hemorrhage was. This was the only statistically significant treatment outcome, although the difference was not significant until (7) 3 (7) * p < 0.01. Fig. 2 . Graph showing actuarial obliteration rates for patients presenting with ICH.
6 months posthemorrhage (Groups 1 and 2). A previous study reported that the risk of rebleeding was highest in the first 6 months, approaching 10% of patients. 2 This could also have affected our results, but in our series, the risk of rebleeding after the first hemorrhage was 6% per year, 4 which does not pose a problem in this study. From this result, one might consider that GKS should be applied soon after hemorrhage. However, we do not have sufficient rationale for immediate treatment, because this retrospective study includes more than a few selection biases. In practice, we occasionally waited for the resolution of a hematoma, or sometimes did not wait and applied GKS 1 or 2 months after hemorrhage even in a case with ICH from time to time. It would be reasonable to show a correlation between the hematoma volume and the timing of the GKS procedure, because large hematomas could lead to significant delays in offering intervention. However, we do not have sufficient data of hemorrhage volume. Instead, we analyzed a subgroup of patients who presented with ICH to identify the influence of ICH on the results. Because ruptured aneurysms are at risk for immediate rerupture, clipping or coiling at acute phase is a standard treatment. 7 On the other hand, based on our analysis, an interval of ≤ 6 months before GKS for ruptured AVMs would be acceptable from the standpoint of preventing repeated hemorrhage.
Intracerebral hemorrhage at the initial presentation was not a determinant of outcome in this study. This could be a result of selection bias or the limited number of patients, and the contribution of ICH might be too small to detect. Another reason might be that we did not distinguish massive and small ICHs. The risk of hemorrhage after GKS until obliteration was almost constant, independent of the interval until treatment. This interesting finding supported our previous finding that the hemorrhagic risk was reduced after GKS until obliteration.
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Conclusions
No apparent benefit was detected in waiting for several months for hematoma absorption until GKS after hemorrhage from AVMs. The risk of hemorrhage increased during the waiting time of > 6 months after hemorrhage. Based on our study, we recommend applying GKS within 6 months after hemorrhage from brain AVMs.
